Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding.
We have used a homology model of the extracellular domain of the 5-HT(3) receptor to dock granisetron, a 5-HT(3) receptor antagonist, into the binding site using AUTODOCK. This yielded 13 alternative energetically favorable models. The models fell into 3 groups. In model type A the aromatic rings of granisetron were between Trp-90 and Phe-226 and its azabicyclic ring was between Trp-183 and Tyr-234, in model type B this orientation was reversed, and in model type C the aromatic rings were between Asp-229 and Ser-200 and the azabicyclic ring was between Phe-226 and Asn-128. Residues located no more than 5 A from the docked granisetron were identified for each model; of 26 residues identified, 8 were found to be common to all models, with 18 others being represented in only a subset of the models. To identify which of the docking models best represents the ligand-receptor complex, we substituted each of these 26 residues with alanine and a residue with similar chemical properties. The mutant receptors were expressed in human embryonic kidney (HEK)293 cells and the affinity of granisetron determined using radioligand binding. Mutation of 2 residues (Trp-183 and Glu-129) ablated binding, whereas mutation of 14 other residues caused changes in the [(3)H]granisetron binding affinity in one or both mutant receptors. The data showed that residues both in and close to the binding pocket can affect antagonist binding and overall were found to best support model B.
Thompson
Andrew J
AJ
Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom.
Price
Kerry L
KL
Reeves
David C
DC
Chan
S Ling
SL
Chau
P-L
PL
Lummis
Sarah C R
SC
D000595:Amino Acid Sequence; D001665:Binding Sites; D002460:Cell Line; D003198:Computer Simulation; D004622:Embryo, Mammalian; D005455:Fluorescent Antibody Technique; D017829:Granisetron / Q000378:metabolism*; D006801:Humans; D007668:Kidney; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D044406:Receptors, Serotonin, 5-HT3 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D012702:Serotonin Antagonists / Q000378:metabolism*; D014162:Transfection; D014316:Tritium
D017829:Granisetron; D044406:Receptors, Serotonin, 5-HT3; D012702:Serotonin Antagonists; D014316:Tritium